revisited with the late April pr announcing compan
Post# of 36537
(Total Views: 493)
Posted On: 05/02/2019 1:20:15 PM
revisited with the late April pr announcing company initiatives and source funding.....seems like a big amount of money we are talking about....maybe in the 10,000,000 range or more.....let's dissect a bit...
The financing will be used to fund:
(1) manufacturing of commercial products,
The commercial products that they may be needing is the order for Imres of the 40000 units of the malaria detection kits (maybe 100,000), the ae37 associated costs to do the Merck combo study with the NSABP, around 2,000,000 needed now....and an additional 1,000,000 to launch the ExcellagenO product deployment....
(2) launch a clinical trial of Regentys ECMH in ulcerative colitis,
According to the schedule of payments to satisfy the Regentys deal, only an initial 400,000 and a 600,000 payments were made.....needing an additional 5,000,000 by May 1st of 2019......so almost 1/2 of the 10 million....
(3) complete the acquisitions of revenue generating companies, and to
This is where i got stuck, are they talking about the hospital network that was in the plan, or is it something else.....definitely not veneto, because veneto pays for itself....so no funds needed there....and as joe has stated many times, he is acquiring companies that come with all the hurdles of running a company out of the way.....so most likely when he is speaking about revenue generating companies, he means the hospital network....i believe.....
(4) launch new service lines for the NuGenerex Distribution Solutions MSO network.
some setup costs associated with adding additional states to the mso network......office costs, managers, infrastructure costs, employees.....
so all in all, we got funding finally......am pretty sure its not the toxic variety we are used to getting......because the amounts are very large.....i think to get this funding Mr. Moscato must have sold his soul for it and everything else he owns.....and we must be very grateful for his hard work......he is the miracle man.......you just have to believe.....
The financing will be used to fund:
(1) manufacturing of commercial products,
The commercial products that they may be needing is the order for Imres of the 40000 units of the malaria detection kits (maybe 100,000), the ae37 associated costs to do the Merck combo study with the NSABP, around 2,000,000 needed now....and an additional 1,000,000 to launch the ExcellagenO product deployment....
(2) launch a clinical trial of Regentys ECMH in ulcerative colitis,
According to the schedule of payments to satisfy the Regentys deal, only an initial 400,000 and a 600,000 payments were made.....needing an additional 5,000,000 by May 1st of 2019......so almost 1/2 of the 10 million....
(3) complete the acquisitions of revenue generating companies, and to
This is where i got stuck, are they talking about the hospital network that was in the plan, or is it something else.....definitely not veneto, because veneto pays for itself....so no funds needed there....and as joe has stated many times, he is acquiring companies that come with all the hurdles of running a company out of the way.....so most likely when he is speaking about revenue generating companies, he means the hospital network....i believe.....
(4) launch new service lines for the NuGenerex Distribution Solutions MSO network.
some setup costs associated with adding additional states to the mso network......office costs, managers, infrastructure costs, employees.....
so all in all, we got funding finally......am pretty sure its not the toxic variety we are used to getting......because the amounts are very large.....i think to get this funding Mr. Moscato must have sold his soul for it and everything else he owns.....and we must be very grateful for his hard work......he is the miracle man.......you just have to believe.....
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼